You are advised to consult any further disclosures we make on related subjects in our reports on Form 10-Q, 8-K and 10-K that we provide to the Effect of exchange rate changes on cash Effective Tax Rate

8:00 a.m. Effective Tax Rate Attachment 8

8:00 a.m. Effective Tax Rate Effective Tax Rate

You are advised to consult any further disclosures we make on related subjects in our reports on Form 10-Q, 8-K and 10-K that we provide to the Securities and Exchange Commission. Develop and implement solutions to end plastic waste while supporting AEPW $1.5B investment in key initiatives. 2030 SUSTAINABILITY TARGETS 11 FUTURE GROWTH IN EXCESS OF GDP IS DRIVEN BY: Our company is positioned to sustainably grow at a rate that exceeds GDP. This innovation drives performance and is reflective of consistent, strategic investments in our portfolio…and people. 2020 Pro forma $991 $86 Sustainable Solutions 15 11% 6 Healthcare 28 22% 6 Composites 6 10% 3 Growth in Emerging Regions 44 30% 10 Other 53 10% 7 Sub-total $1,137 15% $118 FX Impact 25 - 2 Synergies - - 11 Incentives, Travel, Other Employee Costs - - (8) 2021 Actual $1,162 17% $123 Q1 2021 ORGANIC SALES AND OPERATING INCOME 18 (1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition Sales Growth Rate Operating Income$ millions 19 Wire & Cable Transportation Industrial Healthcare Packaging Consumer Q1 2020PF Q1 2021 (2) Financial information is presented on a constant currency basis (1,2) (42% of total revenue) (58% of total revenue) Q1 END MARKET SALES PERFORMANCE +17% +14% +8% +10% +8% +22% +5% +24% Q 2 AN D FU LL Y EA R 2021 O U TLO O K $69 $112 $0.42 $0.80 ORGANIC GROWTH PROJECTIONS – Q2 21 Sales Adjusted Operating Income $870 $1,100 + 26% + 62% + 90% (1) (1) (1) (1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition FULL YEAR GUIDANCE INCREASED 22 Sales Adj.

 Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to:  The final amount of charges resulting from the planned North American asset realignment and the Company’s ability to realize anticipated savings and operational benefits from the asset realignment;  Our ability to achieve the strategic and other objectives relating to the acquisition of Spartech Corporation, including any expected synergies;  Our ability to successfully integrate Spartech and achieve the expected results of the acquisition, including, without limitation, the acquisition being accretive;  Disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future;  The financial condition of our customers, including the ability of customers (especially those that may be highly leveraged and those with inadequate liquidity) to maintain their credit availability;  The speed and extent of an economic recovery, including the recovery of the housing market;  Our ability to achieve new business gains;  The effect on foreign operations of currency fluctuations, tariffs, and other political, economic and regulatory risks;  Changes in polymer consumption growth rates in the markets where we conduct business;  Changes in global industry capacity or in the rate at which anticipated changes in industry capacity come online;  Fluctuations in raw material prices, quality and supply and in energy prices and supply;  Production outages or material costs associated with scheduled or unscheduled maintenance programs;  Unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters;  An inability to achieve or delays in achieving or achievement of less than the anticipated financial benefit from initiatives related to working capital reductions, cost reductions, employee productivity goals, and an inability to raise or sustain prices for products or services;  An inability to raise or sustain prices for products or services;  An inability to maintain appropriate relations with unions and employees;  The inability to achieve expected results from our acquisition activities;  Our ability to continue to pay cash dividends;  The amount and timing of repurchases of our common shares, if any; and  Other factors affecting our business beyond our control, including, without limitation, changes in the general economy, changes in interest rates and changes in the rate of inflation.  The above list of factors is not exhaustive.  We undertake no obligation to publicly update forward-looking statements, whether as a result of new information, future events or otherwise. You are advised to consult any further disclosures we make on related subjects in our reports on Form 10-Q, 8-K and 10-K that we provide to the Securities and Exchange Commission. S&P 500 PolyOne Corporation Page 9 2006 YTD 2015 2020 “Where we were” “Where we are” Platinum Vision 1) Operating Income % Specialty: Global Color, Additives & Inks 1.7% 17.2% 20%+ Global Specialty Engineered Materials 1.1% 15.3% 20%+ Designed Structures & Solutions 1.4% (2012) 3.3% 12 – 14% Performance Products & Solutions 5.5% 7.6% 10 – 12% Distribution 2.6% 6.5% 6.5 – 7.5% 2) Specialty Platform % of Operating Income 6.0% 67% 80%+ 3) ROIC (after-tax)* 5.0% 11.7% 15% 4) Adjusted EPS Growth N/A 23 Consecutive Quarters of YOY EPS Growth Double Digit Expansion Proof of Performance & 2020 Goals *ROIC is defined as TTM adjusted operating income after-tax divided by the sum of average debt and equity over a 5 quarter period PolyOne Corporation Page 10 Platinum Vision: Pathway to Accelerated Growth Organic Sales Growth Margin Expansion Share Repurchases Acquisitions PolyOne Corporation Page 11 Innovation Drives Earnings Growth *Percentage of Specialty Platform revenue from products introduced in last five years $20 $53 2006 2014 Research & Development Spending ($ millions) Specialty Platform Vitality Index Progression* 14% 27% 2006 2014 Specialty Platform Gross Margin % 20% 44% 2006 2014 Specialty Vitality Index Target ≥ 35% PolyOne Corporation Page 12 Megatrends Aligned with Key End Markets Decreasing Dependence on Fossil Fuels Protecting the Environment Improving Health and Wellness Megatrend End Markets Globalizing and Localizing Health & Wellness Transportation Packaging Consumer PolyOne Corporation Page 13 Prototype Frame Opportunity Scale-up & Test Market Build Business Case Commercial Launch Phase 1 Phase 2 Phase 3 Phase 4 Phase 5 6 9 7 3 5 12 5 3 2 8 4 2 4 3 1 Breakthrough Platform Derivative A Rich Pipeline of Opportunity Number of Projects 14 8 18 12 22 74 Addressable Market ($ millions) $700 $600 $600 $1,900 PolyOne Corporation Page 14 60% 102% 20% 30% 40% 50% 60% 70% 80% 90% 100% 2008 Q2 2015 Pension Funding** As of June 30, 2015 Debt Maturities & Pension Funding Net Debt / Adjusted EBITDA** = 2.0x Coupon Rate: 7.500% Variable* 7.375% 5.250% ** includes US-qualified pension plans only *Weighted average rate on revolver was 2.40% as of 6/30/15 **TTM 6/30/2015 $49 $79 $317 $600 $400 $0 $100 $200 $300 $400 $500 $600 $700 $800 2015 2018 2020 2023 Debt Maturities As of June 30, 2015 ($ millions) PolyOne Corporation Page 15 Free Cash Flow and Strong Balance Sheet Fund Investment / Shareholder Return  Expanding our sales, marketing, and technical capabilities  Investing in operational and LSS initiatives  ~75% of capital expenditures fund growth initiatives Organic Growth Acquisitions Share Repurchases Dividends $0.16 $0.20 $0.24 $0.32 $0.40 $0.10 $0.20 $0.30 $0.40 $0.50 2011 2012 2013 2014 2015 Annual Dividend  Targets that expand our: • Specialty offerings • End market presence • Geographic breadth  Synergy opportunities  Adjacent material solutions  Repurchased nearly 600K shares in Q2 2015  Repurchased 12.4 million shares since early 2013  7.6 million shares are available for repurchase under the current authorization PolyOne Corporation Page 16 PolyOne Core Values Innovation Collaboration Excellence PolyOne Corporation Page 17 The New PolyOne: A Specialty Growth Company Why Invest In PolyOne?

WithStand™ Antimicrobial Technology: •    Additive that helps hospitals in non-acute care settings where minor lapses in cleaning protocol can lead to medical device performance problems •    Proven performance in engineered medical grade polymers with efficacy against primary known antibiotic-resistant organisms   OnCap™ Lasermarking Additive: •    Enables permanent alphanumeric character, graphic or barcode information for identification that does not fade over time for Unique Device Identification (UDI) •    Provides consistent and efficient marking without altering, damaging or changing electrical or mechanical properties in sensitive medical devices   OnColor™ HC and HC Plus Colorants: •    Regulatory compliant and biocompatible solid colorants •    Enable confidence that brand color choice will perform as expected for regulatory requirements, performance, and conditions of use   Royalite™ Fire-Rated ABS Sheet: •    Helps meet stringent flame rating requirements while creating thermoformed housings and components  •    Aesthetically appealing and easily machined and finished

Accordingly, we expect first quarter adjusted EPS of $0.68, up 8% from $0.63 in 2023." Avient will provide additional details on its 2023 fourth quarter performance and 2024 outlook during its webcast scheduled for 8:00 a.m. Webcast Details Avient will host a webcast on Wednesday, February 14, 2024 at 8:00 a.m.

The company noted it will provide more details on its second quarter results and outlook during the webcast scheduled for 8:00 a.m. You are advised to consult any further disclosures we make on related subjects in our reports on Form 10-Q, 8-K and 10-K that we provide to the Securities and Exchange Commission. Three Months Ended June 30, 2021 2020 GAAP Results Special Items Adjusted Results GAAP Results Special Items Adjusted Results $ 89.8 $ 14.2 $ 104.0 $ 31.3 $ 2.4 $ 33.7 Income tax expense - GAAP (20.4) — (20.4) (7.9) — (7.9) Income tax impact of special items (Attachment 3) — (3.4) (3.4) — (0.7) (0.7) Tax adjustments (Attachment 3) — 0.9 0.9 — 0.9 0.9 Income tax (expense) benefit $ (20.4) $ (2.5) $ (22.9) $ (7.9) $ 0.2 $ (7.7) Effective Tax Rate(1) 22.7 % 22.0 % 25.1 % 22.5 % (1) Rates may not recalculate from figures presented herein due to rounding 13 Six Months Ended June 30, 2021 2020 GAAP Results Special Items Adjusted Results GAAP Results Special Items Adjusted Results $ 192.4 $ 16.6 $ 209.0 $ 76.3 $ 12.0 $ 88.3 Income tax expense - GAAP (43.3) — (43.3) (19.8) — (19.8) Income tax impact of special items (Attachment 3) — (4.3) (4.3) — (2.7) (2.7) Tax adjustments (Attachment 3) — 2.0 2.0 — 1.9 1.9 Income tax (expense) benefit $ (43.3) $ (2.3) $ (45.6) $ (19.8) $ (0.8) $ (20.6) Effective Tax Rate(1) 22.5 % 21.8 % 25.9 % 23.3 % (1) Rates may not recalculate from figures presented herein due to rounding The following pro forma adjustments are referenced by management to provide comparable business performance by incorporating the Clariant Masterbatch business in periods prior to the acquisition date (July 1, 2020).